Skip to main content
Premium Trial:

Request an Annual Quote

David Cooper, Edward McCabe, Geoffrey Duyk, Frank McCormick


David Cooper, former chief medical officer for NimbleGen Systems of Iceland, has been named to the board of directors of Health Discovery Corp., formerly Direct Wireless Communications, of Waco, Texas, the company said last week. Cooper also was the former chief science officer and chief operating officer for Question Diagnostics, Nichols Institute, in San Juan Capistrano, Calif. He additionally worked as vice president and chief science officer for diaDexus of Santa Clara, Calif. Cooper holds a PhD in chemistry from Florida State University and an MD from the University of Florida, Gainesville.

Edward McCabe has joined the board of advisors at GeneFluidics, of Monterey Park, Calif., the com-pany said Nov. 3. McCabe is chairman of the department of pediatrics at UCLA Medical School. He is also chair of the US Department of Health and Human Services Secretary’s Advisory Committee on Genetics, Health, and Society.

Geoffrey Duyk will leave his post of president, research and development, and chief scientific officer at Exelixis at the end of the year to pursue other professional oppor-tunities, the company said Oct. 30. Frank McCormick, an Exelixis’ board member, will step up his advisory role on the company’s R&D. Duyk joined Exelixis in 1997.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.